← Leaderboards
William R Crom
St. Jude Children'S Research Hospital
$738,742
Attributed
$738,742
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$738,742 · 1
By mechanism
P01$738,742 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Suzanne J Baker$15,879,154
- Michael A Dyer$24,988,379
- Mary-Ann Bjornsti$8,611,236
- Richard James Gilbertson$38,555,720
- Martine F Roussel$7,153,067
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsCamptothecinCerebrospinal FluidClinical ResearchCytotoxicityDisease /Disorder ModelDosageDrug Administration Rate /DurationExtracellular MatrixHuman TissueLaboratory MouseMacaca MulattaMedulloblastomaMicrodialysisModel Design /DevelopmentNeoplasm /Cancer ChemotherapyNeoplasm /Cancer PharmacologyNeuroblastomaPediatric Neoplasm /CancerPharmacokineticsRhabdomyosarcoma
Grant awards (3)
PHARMACOKINETICS/PHARMACODYNAMICS OF ANTICANCER DRUGS IN CHILDHOOD SOLID TUMORS$285,821
P01 · FY2001 · CA
PHARMACOKINETICS/PHARMACODYNAMICS OF ANTICANCER DRUGS IN CHILDHOOD SOLID TUMORS$285,821
P01 · FY2001 · CA
PHARMACOKINETICS/PHARMACODYNAMICS OF ANTICANCER DRUGS IN CHILDHOOD SOLID TUMORS$167,100
P01 · FY2000 · CA